News
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...
The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement ...
According to a statement that was released by Novavax on Wednesday, it appears that the Food and Drug Administration (FDA) of the United States of America will shortly give the COVID-19 vaccine its ...
Novavax said on Wednesday the U.S. Food and Drug Administration had asked the company to produce more data on its COVID-19 ...
Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...
On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...
Pfizer is a pharmaceutical and biotechnology company that developed a COVID-19 vaccine that was approved by the FDA in August 2021. The three top individual/insider shareholders in Pfizer are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results